PHN/ PLPHN0000014 /
| 2024-04-19 5:00:00 PM | Chg. +0.05 | Volume | Bid9:10:00 PM | Ask9:10:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 11.85PLN | +0.42% | 182 Turnover: 2,139.60 |
-Bid Size: - | -Ask Size: - | 11.85 | 11.75 |
GlobeNewswire
01-07
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generat...
GlobeNewswire
2023-10-03
Rita And Alex Hillman Foundation Doubles Funding For Early-Stage, Nursing-Driven Innovations
GlobeNewswire
2023-09-12
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) ...
GlobeNewswire
2023-09-12
Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate...
GlobeNewswire
2023-09-07
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) f...
GlobeNewswire
2023-08-15
Velatura HIE Corporation and Premier Health Network Announce Launch of CareConvene in Georgia
Newsfile Corp
2023-01-17
Acasti Pharma Discusses Positive Clinical Study Results for GTX-101 and GTX-102 and Upcoming Phase 3...
Newsfile Corp
2022-09-21
Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day ...
Newsfile Corp
2022-07-07
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day P...
GlobeNewswire
2022-03-22
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan
GlobeNewswire
2022-03-20
Sorrento Reports Promising Results With a Universal Chimeric mRNA COVID-19 Vaccine That Elicits Pote...
GlobeNewswire
2022-03-17
Scilex Holding Company, a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., to Become Public...
GlobeNewswire
2022-03-09
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
GlobeNewswire
2022-03-02
Sorrento Announces COVISHIELD (STI-9199) Antibody Nasal Drops Prevent Productive SARS-CoV-2 Infectio...
GlobeNewswire
2022-03-02
Sorrento Announces FDA Authorization to Proceed With Phase 1 Study Of Intranasal STI-9199 (COVISHIEL...
GlobeNewswire
2022-03-02
NX Development Corp. (NXDC) Names Salvatore DeSena, M.D., as Chief Executive Officer
GlobeNewswire
2022-02-28
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Cli...
GlobeNewswire
2022-02-17
Sorrento Announces That It Has Acquired a Majority Ownership in Diagnostic Manufacturer Zhengzhou Fo...
GlobeNewswire
2022-02-14
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022
GlobeNewswire
2022-02-07
Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call
GlobeNewswire
2022-01-28
Sorrento Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly Neutralize...
